CNC vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 17, 2026

CNC

38.5
AI Score
VS
CLOV Wins

CLOV

39.0
AI Score

Investment Advisor Scores

CNC

39score
Recommendation
SELL

CLOV

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNC CLOV Winner
Revenue 103.52B 1.49B CNC
Net Income 2.63B 55.34M CNC
Net Margin 2.5% 3.7% CLOV
Operating Income 3.06B 55.34M CNC
ROE 11.7% 14.7% CLOV
ROA 3.2% 7.7% CLOV
Total Assets 83.01B 720.33M CNC
Current Ratio 1.15 1.50 CLOV
Free Cash Flow 7.58B 131.55M CNC

Relative Price Performance (Last 90 Days)

CNC 1M: +2.5% · 3M: +7.5% CLOV 1M: +6.8% · 3M: -7.7%

Current Technical Phase

CNC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.8% over 20 days), RSI 50

RSI (14): 50.2 · Price: $66.01

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.1 · Price: $4.56

Fundamentals Snapshot

Metric CNC CLOV
Market Cap
Forward P/E 12.4 28.8
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.6%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.0%
EPS -10.36 -0.05
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.